{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:47:19Z","timestamp":1792194439955,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:00:00Z","timestamp":1610755200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:00:00Z","timestamp":1610755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s11060-020-03691-6","type":"journal-article","created":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T15:02:28Z","timestamp":1610809348000},"page":"173-182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Local control and patterns of failure for \u201cRadioresistant\u201d spinal metastases following stereotactic body radiotherapy compared to a \u201cRadiosensitive\u201d reference"],"prefix":"10.1007","volume":"152","author":[{"given":"K. Liang","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Sahgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain A.","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sten","family":"Myrehaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Lin","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Detsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Sarfehnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ruschin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikki","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunit","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Lipsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg A.","family":"Bjarnason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshetu G.","family":"Atenafu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pejman Jabehdar","family":"Maralani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2824-2100","authenticated-orcid":false,"given":"Hany","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,16]]},"reference":[{"issue":"15","key":"3691_CR1","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1016\/j.ejca.2010.04.025","volume":"46","author":"R Harel","year":"2010","unstructured":"Harel R, Angelov L (2010) Spine metastases: current treatments and future directions. Eur J Cancer 46(15):2696\u20132707. https:\/\/doi.org\/10.1016\/j.ejca.2010.04.025","journal-title":"Eur J Cancer"},{"issue":"1","key":"3691_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.prro.2016.08.001","volume":"7","author":"S Lutz","year":"2016","unstructured":"Lutz S, Balboni T, Jones J et al (2016) Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol 7(1):4\u201312. https:\/\/doi.org\/10.1016\/j.prro.2016.08.001","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"3691_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3171\/2017.1.SPINE16684","volume":"27","author":"ZA Husain","year":"2017","unstructured":"Husain ZA, Sahgal A, Salles AD et al (2017) Stereotactic body radiotherapy for de novo spinal metastases: systematic review: International Stereotactic Radiosurgery Society practice guidelines. J Neurosurg Spine 27(3):295\u2013302. https:\/\/doi.org\/10.3171\/2017.1.SPINE16684","journal-title":"J Neurosurg Spine"},{"issue":"3","key":"3691_CR4","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ijrobp.2008.02.060","volume":"71","author":"A Sahgal","year":"2008","unstructured":"Sahgal A, Larson DA, Chang EL (2008) Stereotactic body radiosurgery for spinal metastases: a critical review. Int J Radiat Oncol Biol Phys 71(3):652\u2013665. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.02.060","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"3691_CR5","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/j.ijrobp.2011.06.1980","volume":"82","author":"D Hyde","year":"2012","unstructured":"Hyde D, Lochray F, Korol R et al (2012) Spine stereotactic body radiotherapy utilizing cone-beam CT image-guidance with a robotic couch: intrafraction motion analysis accounting for all six degrees of freedom. Int J Radiat Oncol Biol Phys 82(3):e555-562. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.06.1980","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"3691_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jmir.2013.04.002","volume":"44","author":"A Sangha","year":"2013","unstructured":"Sangha A, Korol R, Sahgal A (2013) Stereotactic body radiotherapy for the treatment of spinal metastases: an overview of the University of Toronto, Sunnybrook Health Sciences Odette Cancer Centre. Technique J Med Imaging Radiat Sci 44(3):126\u2013133. https:\/\/doi.org\/10.1016\/j.jmir.2013.04.002","journal-title":"Technique J Med Imaging Radiat Sci"},{"issue":"3","key":"3691_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ijrobp.2018.06.047","volume":"102","author":"C-L Tseng","year":"2018","unstructured":"Tseng C-L, Soliman H, Myrehaug S et al (2018) Imaging-based outcomes for 24 Gy in 2 daily fractions for patients with de novo spinal metastases treated with spine stereotactic body radiation therapy (SBRT). Int J Radiat Oncol Biol Phys 102(3):499\u2013507. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.06.047","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"3691_CR8","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1172\/JCI97631","volume":"129","author":"S Bodo","year":"2019","unstructured":"Bodo S, Campagne C, Thin TH et al (2019) Single-dose radiotherapy disables tumor cell homologous recombination via ischemia\/reperfusion injury. J Clin Invest 129(2):786\u2013801. https:\/\/doi.org\/10.1172\/JCI97631","journal-title":"J Clin Invest"},{"issue":"19","key":"3691_CR9","doi-asserted-by":"publisher","first-page":"30290","DOI":"10.1016\/j.ijrobp.2019.02.046","volume":"S0360\u20133016","author":"AE Marciscano","year":"2019","unstructured":"Marciscano AE, Haimovitz-Friedman A, Lee P et al (2019) Immunomodulatory effects of stereotactic body radiation therapy: preclinical insights and clinical opportunities. Int J Radiat Oncol Biol Phys S0360\u20133016(19):30290\u201330291. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.02.046","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"22S","key":"3691_CR10","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1097\/BRS.0b013e3181b8b6f5","volume":"34","author":"PC Gerszten","year":"2009","unstructured":"Gerszten PC, Mendel E, Yamada Y (2009) Radiotherapy and radiosurgery for metastatic spine disease: what are the options, indications, and outcomes? Spine 34(22S):S78. https:\/\/doi.org\/10.1097\/BRS.0b013e3181b8b6f5","journal-title":"Spine"},{"issue":"aop","key":"3691_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2020.1.SPINE191260","volume":"1","author":"N Sandhu","year":"2020","unstructured":"Sandhu N, Benson KRK, Kumar KA et al (2020) Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of gastrointestinal origin. J Neurosurg Spine 1(aop):1\u20138. https:\/\/doi.org\/10.3171\/2020.1.SPINE191260","journal-title":"J Neurosurg Spine"},{"issue":"16","key":"3691_CR12","doi-asserted-by":"publisher","first-page":"e595","DOI":"10.1016\/S1470-2045(15)00166-7","volume":"16","author":"I Thibault","year":"2015","unstructured":"Thibault I, Chang EL, Sheehan J et al (2015) Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group. Lancet Oncol 16(16):e595-603. https:\/\/doi.org\/10.1016\/S1470-2045(15)00166-7","journal-title":"Lancet Oncol"},{"key":"3691_CR13","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.radonc.2019.08.018","volume":"142","author":"R Thompson","year":"2020","unstructured":"Thompson R, Cheung P, Chu W et al (2020) Outcomes of extra-cranial stereotactic body radiotherapy for metastatic colorectal cancer: dose and site of metastases matter. Radiother Oncol 142:236\u2013245. https:\/\/doi.org\/10.1016\/j.radonc.2019.08.018","journal-title":"Radiother Oncol"},{"issue":"1","key":"3691_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3171\/2015.11.SPINE151059","volume":"25","author":"JE Leeman","year":"2016","unstructured":"Leeman JE, Bilsky M, Laufer I et al (2016) Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study. J Neurosurg Spine 25(1):52\u201358. https:\/\/doi.org\/10.3171\/2015.11.SPINE151059","journal-title":"J Neurosurg Spine"},{"issue":"6","key":"3691_CR15","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1634\/theoncologist.2012-0293","volume":"18","author":"I Laufer","year":"2013","unstructured":"Laufer I, Rubin DG, Lis E et al (2013) The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist 18(6):744\u2013751. https:\/\/doi.org\/10.1634\/theoncologist.2012-0293","journal-title":"Oncologist"},{"issue":"5","key":"3691_CR16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/neuonc\/noz006","volume":"21","author":"JM Kim","year":"2019","unstructured":"Kim JM, Miller JA, Kotecha R et al (2019) Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis. Neuro Oncol 21(5):659\u2013668. https:\/\/doi.org\/10.1093\/neuonc\/noz006","journal-title":"Neuro Oncol"},{"issue":"2","key":"3691_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3171\/2018.10.JNS182340","volume":"132","author":"S Parsai","year":"2019","unstructured":"Parsai S, Miller JA, Juloori A et al (2019) Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases. J Neurosurg 132(2):503\u2013511. https:\/\/doi.org\/10.3171\/2018.10.JNS182340","journal-title":"J Neurosurg"},{"issue":"3","key":"3691_CR18","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0277-5379(89)90266-6","volume":"25","author":"J Carmichael","year":"1989","unstructured":"Carmichael J, Degraff WG, Gamson J et al (1989) Radiation sensitivity of human lung cancer cell lines. Eur J Cancer Clin Oncol 25(3):527\u2013534. https:\/\/doi.org\/10.1016\/0277-5379(89)90266-6","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"2","key":"3691_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/neuonc\/noz155","volume":"22","author":"SK Balasubramanian","year":"2020","unstructured":"Balasubramanian SK, Sharma M, Venur VA et al (2020) Impact of EGFR mutation and ALK rearrangement on the outcomes of non-small cell lung cancer patients with brain metastasis. Neuro Oncol 22(2):267\u2013277. https:\/\/doi.org\/10.1093\/neuonc\/noz155","journal-title":"Neuro Oncol"},{"issue":"4","key":"3691_CR20","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.prro.2017.01.001","volume":"7","author":"JA Miller","year":"2017","unstructured":"Miller JA, Kotecha R, Ahluwalia MS et al (2017) The impact of tumor biology on survival and response to radiation therapy among patients with non-small cell lung cancer brain metastases. Pract Radiat Oncol 7(4):e263\u2013e273. https:\/\/doi.org\/10.1016\/j.prro.2017.01.001","journal-title":"Pract Radiat Oncol"},{"issue":"5","key":"3691_CR21","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","volume":"6","author":"R Phillips","year":"2020","unstructured":"Phillips R, Shi WY, Deek M et al (2020) Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial. JAMA Oncol 6(5):650\u2013659. https:\/\/doi.org\/10.1001\/jamaoncol.2020.0147","journal-title":"JAMA Oncol"},{"issue":"2","key":"3691_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0167-8140(89)90053-4","volume":"14","author":"G Arcangeli","year":"1989","unstructured":"Arcangeli G, Micheli A, Arcangeli G et al (1989) The responsiveness of bone metastases to radiotherapy: the effect of site, histology and radiation dose on pain relief. Radiother Oncol 14(2):95\u2013101. https:\/\/doi.org\/10.1016\/0167-8140(89)90053-4","journal-title":"Radiother Oncol"},{"issue":"5","key":"3691_CR23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","volume":"36","author":"P Ost","year":"2018","unstructured":"Ost P, Reynders D, Decaestecker K et al (2018) Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial. J Clin Oncol 36(5):446\u2013453. https:\/\/doi.org\/10.1200\/JCO.2017.75.4853","journal-title":"J Clin Oncol"},{"issue":"5","key":"3691_CR24","doi-asserted-by":"publisher","first-page":"e597","DOI":"10.1016\/j.ijrobp.2012.03.009","volume":"83","author":"BW Cox","year":"2012","unstructured":"Cox BW, Spratt DE, Lovelock M et al (2012) International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 83(5):e597-605. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.03.009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"3691_CR25","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.ijrobp.2016.03.027","volume":"95","author":"KJ Redmond","year":"2016","unstructured":"Redmond KJ, Lo SS, Fisher C, Sahgal A (2016) Postoperative stereotactic body radiation therapy (SBRT) for spine metastases: a critical review to guide practice. Int J Radiat Oncol Biol Phys 95(5):1414\u20131428. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.03.027","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3691_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.radonc.2019.11.026","volume":"145","author":"EM Dunne","year":"2020","unstructured":"Dunne EM, Sahgal A, Lo SS et al (2020) International consensus recommendations for target volume delineation specific to sacral metastases and spinal stereotactic body radiation therapy (SBRT). Radiother Oncol 145:21\u201329. https:\/\/doi.org\/10.1016\/j.radonc.2019.11.026","journal-title":"Radiother Oncol"},{"issue":"2","key":"3691_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ijrobp.2012.05.007","volume":"85","author":"A Sahgal","year":"2013","unstructured":"Sahgal A, Weinberg V, Ma L et al (2013) Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice. Int J Radiat Oncol Biol Phys 85(2):341\u2013347. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.05.007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"19","key":"3691_CR28","doi-asserted-by":"publisher","first-page":"33862","DOI":"10.1016\/j.ijrobp.2019.09.038","volume":"S0360\u20133016","author":"A Sahgal","year":"2019","unstructured":"Sahgal A, Chang JH, Ma L et al (2019) Spinal cord dose tolerance to stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys S0360\u20133016(19):33862\u201333863. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.09.038","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3691_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1748-717X-9-69","volume":"9","author":"CG Fisher","year":"2014","unstructured":"Fisher CG, Schouten R, Versteeg AL et al (2014) Reliability of the Spinal Instability Neoplastic Score (SINS) among radiation oncologists: an assessment of instability secondary to spinal metastases. Radiat Oncol 9:69. https:\/\/doi.org\/10.1186\/1748-717X-9-69","journal-title":"Radiat Oncol"},{"issue":"3","key":"3691_CR30","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3171\/2010.3.SPINE09459","volume":"13","author":"MH Bilsky","year":"2010","unstructured":"Bilsky MH, Laufer I, Fourney DR et al (2010) Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine 13(3):324\u2013328. https:\/\/doi.org\/10.3171\/2010.3.SPINE09459","journal-title":"J Neurosurg Spine"},{"issue":"3","key":"3691_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/neuros\/nyy075","volume":"84","author":"P Jabehdar Maralani","year":"2018","unstructured":"Jabehdar Maralani P, Winger K, Symons S et al (2018) Incidence and time of onset of osseous pseudoprogression in patients with metastatic spine disease from renal cell or prostate carcinoma after treatment with stereotactic body radiation therapy. Neurosurgery 84(3):647\u2013654. https:\/\/doi.org\/10.1093\/neuros\/nyy075","journal-title":"Neurosurgery"},{"issue":"5","key":"3691_CR32","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.ijrobp.2018.07.2023","volume":"102","author":"AJ Ghia","year":"2018","unstructured":"Ghia AJ, Guha-Thakurta N, Hess K et al (2018) Phase 1 study of spinal cord constraint relaxation with single session spine stereotactic radiosurgery in the primary management of patients with inoperable, previously unirradiated metastatic epidural spinal cord compression. Int J Radiat Oncol Biol Phys 102(5):1481\u20131488. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.07.2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"3691_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3171\/SPI-07\/08\/151","volume":"7","author":"EL Chang","year":"2007","unstructured":"Chang EL, Shiu AS, Mendel E et al (2007) Phase I\/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 7(2):151\u2013160. https:\/\/doi.org\/10.3171\/SPI-07\/08\/151","journal-title":"J Neurosurg Spine"},{"issue":"4","key":"3691_CR34","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3171\/2015.6.SPINE15294","volume":"24","author":"MW Chan","year":"2016","unstructured":"Chan MW, Thibault I, Atenafu EG et al (2016) Patterns of epidural progression following postoperative spine stereotactic body radiotherapy: implications for clinical target volume delineation. J Neurosurg Spine 24(4):652\u2013659. https:\/\/doi.org\/10.3171\/2015.6.SPINE15294","journal-title":"J Neurosurg Spine"},{"issue":"2","key":"3691_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ijrobp.2015.03.029","volume":"93","author":"I Thibault","year":"2015","unstructured":"Thibault I, Campbell M, Tseng C-L et al (2015) Salvage stereotactic body radiotherapy (SBRT) following in-field failure of initial SBRT for spinal metastases. Int J Radiat Oncol Biol Phys 93(2):353\u2013360. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.03.029","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"3691_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3171\/2012.11.SPINE12111","volume":"18","author":"I Laufer","year":"2013","unstructured":"Laufer I, Iorgulescu JB, Chapman T et al (2013) Local disease control for spinal metastases following \u201cseparation surgery\u201d and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients. J Neurosurg Spine 18(3):207\u2013214. https:\/\/doi.org\/10.3171\/2012.11.SPINE12111","journal-title":"J Neurosurg Spine"},{"issue":"6","key":"3691_CR37","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1093\/neuros\/nyy176","volume":"84","author":"R Jakubovic","year":"2019","unstructured":"Jakubovic R, Ruschin M, Tseng C-L, Pejovi\u0107-Mili\u0107 A, Sahgal A, Yang VXD (2019) Surgical resection with radiation treatment planning of spinal tumors. Neurosurgery 84(6):1242\u20131250. https:\/\/doi.org\/10.1093\/neuros\/nyy176","journal-title":"Neurosurgery"},{"issue":"1","key":"3691_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7785\/tcrt.2012.500230","volume":"11","author":"E Massicotte","year":"2012","unstructured":"Massicotte E, Foote M, Reddy R, Sahgal A (2012) Minimal access spine surgery (MASS) for decompression and stabilization performed as an out-patient procedure for metastatic spinal tumours followed by spine stereotactic body radiotherapy (SBRT): first report of technique and preliminary outcomes. Technol Cancer Res Treat 11(1):15\u201325. https:\/\/doi.org\/10.7785\/tcrt.2012.500230","journal-title":"Technol Cancer Res Treat"},{"issue":"15","key":"3691_CR39","doi-asserted-by":"publisher","first-page":"TPS10129","DOI":"10.1200\/JCO.2017.35.15_suppl.TPS10129","volume":"35","author":"A Sahgal","year":"2017","unstructured":"Sahgal A, Myrehaug S, Dennis K et al (2017) A randomized phase II\/III study comparing stereotactic body radiotherapy (SBRT) versus conventional palliative radiotherapy (CRT) for patients with spinal metastases (NCT02512965). J Clin Oncol 35(15):TPS10129. https:\/\/doi.org\/10.1200\/JCO.2017.35.15_suppl.TPS10129","journal-title":"J Clin Oncol"},{"key":"3691_CR40","unstructured":"Sahgal A, Myrehaug S, Siva S, et al (2020) CCTG SC.24\/TROG 17.06: a randomized phase II\/III study comparing 24Gy in 2 stereotactic body radiotherapy (SBRT) fractions versus 20Gy in 5 conventional palliative radiotherapy (CRT) fractions for patients with painful spinal metastases. Presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting Abstract #: LBA 2. Published online 2020."},{"issue":"3","key":"3691_CR41","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1200\/JCO.2015.61.9338","volume":"34","author":"MG Fehlings","year":"2016","unstructured":"Fehlings MG, Nater A, Tetreault L et al (2016) Survival and clinical outcomes in surgically treated patients with metastatic epidural spinal cord compression: results of the prospective multicenter AOSpine study. J Clin Oncol 34(3):268\u2013276. https:\/\/doi.org\/10.1200\/JCO.2015.61.9338","journal-title":"J Clin Oncol"},{"issue":"2","key":"3691_CR42","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ijrobp.2007.11.046","volume":"71","author":"Y Yamada","year":"2008","unstructured":"Yamada Y, Bilsky MH, Lovelock DM et al (2008) High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 71(2):484\u2013490. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.11.046","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"30","key":"3691_CR43","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1200\/JCO.2008.19.3508","volume":"27","author":"PS Rose","year":"2009","unstructured":"Rose PS, Laufer I, Boland PJ et al (2009) Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. J Clin Oncol 27(30):5075\u20135079. https:\/\/doi.org\/10.1200\/JCO.2008.19.3508","journal-title":"J Clin Oncol"},{"issue":"27","key":"3691_CR44","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1200\/JCO.2013.50.1411","volume":"31","author":"A Sahgal","year":"2013","unstructured":"Sahgal A, Atenafu EG, Chao S et al (2013) Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score. J Clin Oncol 31(27):3426\u20133431. https:\/\/doi.org\/10.1200\/JCO.2013.50.1411","journal-title":"J Clin Oncol"},{"issue":"10","key":"3691_CR45","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/neuonc\/not101","volume":"15","author":"A Al-Omair","year":"2013","unstructured":"Al-Omair A, Masucci L, Masson-Cote L et al (2013) Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy. Neuro-Oncol 15(10):1413\u20131419. https:\/\/doi.org\/10.1093\/neuonc\/not101","journal-title":"Neuro-Oncol"},{"issue":"6","key":"3691_CR46","doi-asserted-by":"publisher","first-page":"E1111","DOI":"10.1093\/neuros\/nyz349","volume":"85","author":"M Alghamdi","year":"2019","unstructured":"Alghamdi M, Sahgal A, Soliman H et al (2019) Postoperative stereotactic body radiotherapy for spinal metastases and the impact of epidural disease grade. Neurosurgery 85(6):E1111\u2013E1118. https:\/\/doi.org\/10.1093\/neuros\/nyz349","journal-title":"Neurosurgery"},{"issue":"5","key":"3691_CR47","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ijrobp.2017.08.028","volume":"99","author":"V Bernard","year":"2017","unstructured":"Bernard V, Bishop AJ, Allen PK et al (2017) Heterogeneity in treatment response of spine metastases to spine stereotactic radiosurgery within \u201cRadiosensitive\u201d subtypes. Int J Radiat Oncol Biol Phys 99(5):1207\u20131215. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.08.028","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"3691_CR48","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3171\/2017.2.SPINE16976","volume":"27","author":"S Myrehaug","year":"2017","unstructured":"Myrehaug S, Sahgal A, Hayashi M et al (2017) Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review. J Neurosurg Spine 27(4):428\u2013435. https:\/\/doi.org\/10.3171\/2017.2.SPINE16976","journal-title":"J Neurosurg Spine"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03691-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-020-03691-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03691-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T08:26:22Z","timestamp":1614327982000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-020-03691-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,16]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["3691"],"URL":"https:\/\/doi.org\/10.1007\/s11060-020-03691-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,16]]},"assertion":[{"value":"27 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Arjun Sahgal is an advisor\/consultant with Abbvie, Merck, Roche, Varian (Medical Advisory Group), Elekta (Gamma Knife Icon), BrainLAB, and VieCure (Medical Advisory Board), Board Member: International Stereotactic Radiosurgery Society (ISRS), has had past educational seminars with Elekta AB, Accuray Inc., Varian (CNS Teaching Faculty), BrainLAB, Medtronic Kyphon, received research grants with Elekta AB and Travel accommodations\/expenses by Elekta, Varian, BrainLAB and belongs to the Elekta MR Linac Research Consortium, Elekta Spine, Oligometastases and Linac Based SRS Consortia. Zain Husain has received travel accommodations from Elekta AB. Hany Soliman has received grants for educational event from Elekta AB. Chia-Lin Tseng has received travel accommodations\/expenses & honoraria for past educational seminars by Elekta, belongs to the Elekta MR-Linac Research Consortium, and is an advisor\/consultant with Sanofi.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}